C
COGT
Cogent Biosciences Inc
35.62
+0.20+0.56%After Hours: 36.75 +1.13 +3.17%19:54 04/07 EDT
OPEN/PREV CLOSE35.09/35.42
TODAY RANGE34.26-35.67
VOL2.59M
MARKET CAP5.78B
52 WEEK RANGE3.720-43.73
AVG VOL (3M)2.14M
% TURNOVER1.60%
TURNOVER--
P/E (TTM)-16.5221
% RANGE3.97%
EPS(TTM)-2.1559
P/E(FORWARD)-15.8664
P/B9.01
BVPS3.953
DIVIDEND--
P/S15.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.70B
SHARES OUTSTANDING162.31M
NEXT EARNINGS05/04-05/08
FREE FLOAT160.11M
LOT SIZE1
EX-DATE11/09/2020
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
A Look At Cogent Biosciences (COGT) Valuation After FDA Acceptance Of Bezuclastinib NDA
TipRanks·4d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
Seeking Alpha·5d ago
Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy'
Simply Wall St·6d ago
Cogent Biosciences (COGT) Is Up 5.5% After FDA NDA Filing For Bezuclastinib In GIST - Has The Bull Case Changed?
Simply Wall St·03/24 20:11
Assessing Cogent Biosciences (COGT) Valuation After FDA NDA Acceptance And Rising Institutional Interest
TipRanks·03/21 14:57
LifeSci Capital Sticks to Their Buy Rating for Cogent Biosciences (COGT)
Simply Wall St·03/19 08:12
How FDA Acceptance of Bezuclastinib NDA and SUMMIT Data Will Impact Cogent Biosciences (COGT) Investors
TipRanks·03/17 13:16
Wedbush Keeps Their Buy Rating on Cogent Biosciences (COGT)
Same Industry
Name/Symbol
Change%
Price